216 related articles for article (PubMed ID: 1737360)
1. Chemically induced forestomach papillomas in transgenic mice carry mutant human c-Ha-ras transgenes.
Ando K; Saitoh A; Hino O; Takahashi R; Kimura M; Katsuki M
Cancer Res; 1992 Feb; 52(4):978-82. PubMed ID: 1737360
[TBL] [Abstract][Full Text] [Related]
2. Chemically induced tumors in transgenic mice carrying prototype human c-Ha-ras genes.
Katsuki M; Ando K; Saitoh A; Doi S; Kimura M; Takahashi R; Hasegawa T; Yokoyama M; Nomura T; Izawa M
Princess Takamatsu Symp; 1991; 22():249-57. PubMed ID: 1844246
[TBL] [Abstract][Full Text] [Related]
3. Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes.
Saitoh A; Kimura M; Takahashi R; Yokoyama M; Nomura T; Izawa M; Sekiya T; Nishimura S; Katsuki M
Oncogene; 1990 Aug; 5(8):1195-200. PubMed ID: 2202951
[TBL] [Abstract][Full Text] [Related]
4. An overexpressed N-ras proto-oncogene cooperates with N-methylnitrosourea in mouse mammary carcinogenesis.
Mangues R; Kahn JM; Seidman I; Pellicer A
Cancer Res; 1994 Dec; 54(24):6395-401. PubMed ID: 7987834
[TBL] [Abstract][Full Text] [Related]
5. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.
Wang XJ; Liefer KM; Greenhalgh DA; Roop DR
Mol Carcinog; 1999 Dec; 26(4):305-11. PubMed ID: 10569807
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of chemical carcinogenesis in vivo by azatyrosine.
Izawa M; Takayama S; Shindo-Okada N; Doi S; Kimura M; Katsuki M; Nishimura S
Cancer Res; 1992 Mar; 52(6):1628-30. PubMed ID: 1540971
[TBL] [Abstract][Full Text] [Related]
7. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
8. Chemically induced lung and forestomach neoplasias in transgenic mice carry mutant forms of the human c-Ha-ras transgene.
Ogawa K; Imaida K; Masui T; Kawabe M; Hasegawa R; Kato K; Ito N; Shirai T
Carcinogenesis; 1996 Feb; 17(2):341-5. PubMed ID: 8625461
[TBL] [Abstract][Full Text] [Related]
9. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
10. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
[TBL] [Abstract][Full Text] [Related]
11. Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis.
Wang XJ; Greenhalgh DA; Jiang A; He D; Zhong L; Medina D; Brinkley BR; Roop DR
Oncogene; 1998 Jul; 17(1):35-45. PubMed ID: 9671312
[TBL] [Abstract][Full Text] [Related]
12. Site-specific mutation of the human c-Ha-ras transgene induced by dimethylbenzanthracene causes tissue-specific tumors in mice.
Doi ST; Kimura M; Katsuki M
Jpn J Cancer Res; 1994 Aug; 85(8):801-7. PubMed ID: 7928625
[TBL] [Abstract][Full Text] [Related]
13. Transgenic coexpression of v-Ha-ras and transforming growth factor alpha increases epidermal hyperproliferation and tumorigenesis and predisposes to malignant conversion via endogenous c-Ha-ras activation.
Wang XJ; Greenhalgh DA; Roop DR
Mol Carcinog; 2000 Mar; 27(3):200-9. PubMed ID: 10708482
[TBL] [Abstract][Full Text] [Related]
14. Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways.
Jhappan C; Takayama H; Dickson RB; Merlino G
Cell Growth Differ; 1994 Apr; 5(4):385-94. PubMed ID: 8043512
[TBL] [Abstract][Full Text] [Related]
15. Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg.AC transgenic mice and FVB/N mice.
Tober KL; Cannon RE; Spalding JW; Oberyszyn TM; Parrett ML; Rackoff AI; Oberyszyn AS; Tennant RW; Robertson FM
Biochem Biophys Res Commun; 1998 Jun; 247(3):644-53. PubMed ID: 9647747
[TBL] [Abstract][Full Text] [Related]
16. Embryonal tumors from transgenic mouse zygotes carrying human activated c-Ha-ras genes.
Katsuki M; Kimura M; Hata J; Takahashi R; Nozawa S; Yokoyama M; Izawa M; Sekiya T; Nishimura S; Nomura T
Mol Biol Med; 1989 Dec; 6(6):567-72. PubMed ID: 2483936
[TBL] [Abstract][Full Text] [Related]
17. Cell-type-specific ras mutations but no microsatellite instability in chemically induced mouse skin tumors and transformed 3T3 cells.
Sasaki K; Bertrand O; Nakazawa H; Fitzgerald DJ; Mironov N; Yamasaki H
Cancer Res; 1995 Aug; 55(16):3513-6. PubMed ID: 7627957
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
[TBL] [Abstract][Full Text] [Related]
19. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
Goodrow T; Reynolds S; Maronpot R; Anderson M
Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of mutated Ha-ras during premalignant progression in SENCAR mouse skin.
Rodriguez-Puebla ML; LaCava M; Bolontrade MF; Russell J; Conti CJ
Mol Carcinog; 1999 Nov; 26(3):150-6. PubMed ID: 10559789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]